APA

Chekenya M., Krakstad C., Svendsen A., Netland I. A., Staalesen V., Tysnes B. B., Selheim F., Wang J., Sakariassen P. Ø., Sandal T., Lønning P. E., Flatmark T., Enger P. Ø., Bjerkvig R., Sioud M. & Stallcup W. B. (20080930). The progenitor cell marker NG2/MPG promotes chemoresistance by activation of integrin-dependent PI3K/Akt signaling. : Oncogene.

Chicago

Chekenya M, Krakstad C, Svendsen A, Netland I A, Staalesen V, Tysnes B B, Selheim F, Wang J, Sakariassen P Ø, Sandal T, Lønning P E, Flatmark T, Enger P Ø, Bjerkvig R, Sioud M and Stallcup W B. 20080930. The progenitor cell marker NG2/MPG promotes chemoresistance by activation of integrin-dependent PI3K/Akt signaling. : Oncogene.

Harvard

Chekenya M., Krakstad C., Svendsen A., Netland I. A., Staalesen V., Tysnes B. B., Selheim F., Wang J., Sakariassen P. Ø., Sandal T., Lønning P. E., Flatmark T., Enger P. Ø., Bjerkvig R., Sioud M. and Stallcup W. B. (20080930). The progenitor cell marker NG2/MPG promotes chemoresistance by activation of integrin-dependent PI3K/Akt signaling. : Oncogene.

MLA

Chekenya M, Krakstad C, Svendsen A, Netland I A, Staalesen V, Tysnes B B, Selheim F, Wang J, Sakariassen P Ø, Sandal T, Lønning P E, Flatmark T, Enger P Ø, Bjerkvig R, Sioud M and Stallcup W B. The progenitor cell marker NG2/MPG promotes chemoresistance by activation of integrin-dependent PI3K/Akt signaling. : Oncogene. 20080930.